Asston Pharmaceuticals Ltd Share Price Today - Asston Pharmaceuticals Ltd Stock Price Live NSE/BSE

Asston Pharmaceuticals Ltd

NSE: BSE: 544445

₹81

(4.15%)

Fri, 08 May 2026, 04:36 pm

MTF 5xInvest in Asston Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap662.01M

PE Ratio0

Dividend0

Distribution Services

Medical Distributors

24.5K

Asston Pharmaceuticals Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
68.05
Net Profit
3.85
P/B
0
Sector P/E
43.10
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.17
Interest Cover (Industry)
18.19
ROCE (Industry)
20.67
RONW (Industry)
17.71
ROE
42.28
ROCE
36.73
Debt/Equity
0.77
EPS (TTM)
4.48
Dividend Yield
0
Book Value
45.35
Interest Cover
6.27

Analysis

No Result Found

Financials

Ratios

Shareholders	MAR 2026	SEPT 2025	JUN 2025
Promoters	50.66	50.66	50.66
FII	1.91	6.04	9.70
DII	0	0	4.08
Public	47.42	43.30	35.56
Government	0	0	0

Technical Analysis

RSI

51.86

MACD

0.58

50 DMA

78.57

200 DMA

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	128.47	105.83	93.36	83.19	70.72	60.55	37.91
Fibonacci	105.83	97.18	91.84	83.19	74.54	69.20	60.55
Camarilla	87.13	85.05	82.98	83.19	78.82	76.75	74.67

Pivots Level: Classic

+45.28

128.47

+22.64

105.83

+10.18

93.36

83.19

Pivot Point

LTP: 79.94

-12.46

70.72

-22.64

60.55

-45.28

37.91

Moving Average

SMAEMA

Period

Value

10-EMA
79.68
20-EMA
79.15
30-EMA
78.96
50-EMA
79.47
100-EMA
83.06
200-EMA
-

Announcement Date	Purpose	Action
30 Mar 2026	egm
14 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
25 Aug 2025	agm

Asston Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Lupin Ltd

Cipla Ltd

Divis Laboratories Ltd

Asston Pharmaceuticals Ltd About

Asston Pharmaceuticals is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African and Asian markets. Presently our Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion), and Oral Powder (Sachet, Dry Syrup) etc.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

2019

Headquarters

CEO

Employees

Contact

Website

http://www.asstonpharmaceuticals.com

info@asstonpharmaceuticals.com

Phone

+91 22 4973 1411/+91 22 4973 1419

Location

4th Flr Office No.A-431 Balaji, Bhavan Plot No.42A Sec-11 CBD, Mumbai, Maharashtra, 400614

Year	History
2020	The company obtained registered trademarks in India and abroad for multiple products.
2021	The company crossed the turnover mark of 10 cr.
2022	The company established its manufacturing unit in Mumbai.
2023	The company successfully ventured into other African countries. The company is expected to receive registration from Asian markets like Cambodia and Vietnam.
2024	The company was converted from a private limited company to a public limited company. The company name was changed from Asston Pharmaceuticals Private Limited to Asston Pharmaceuticals Limited.

Client Name	Order Side	QTY	Avg Price	Date
KINGSMAN WEALTH FUND PCC - KIF II	Sell	50000	84.12	01 Jan 2026
JSK SECURITIES AND SERVICES PRIVATE LIMITED	Sell	52000	123.37	28 Jul 2025
PRADIP BISHANDAS PANJABI	Sell	45000	117.67	21 Jul 2025
NEHA MISHRA	Sell	50000	119.66	18 Jul 2025
MAHESH VISHNUPANT MULAY	Buy	99000	118.85	16 Jul 2025
PRADIP BISHANDAS PANJABI	Buy	45000	122.01	16 Jul 2025
AMIT RAJENDRA PRASAD AGARWAL	Buy	59000	119	16 Jul 2025
MAHESH VISHNUPANT MULAY	Buy	58000	119	16 Jul 2025
NEHA MISHRA	Buy	50000	119.12	16 Jul 2025

Asston Pharmaceuticals Ltd News

Asston Pharma Submits Q4FY26 Compliance Certificate

Asston Pharmaceuticals Limited submitted its quarterly compliance certificate under SEBI regulations for Q4FY26 to BSE, confirming no dematerialisation activities during the period.

14 Apr 2026

companies

Asston Pharmaceuticals EGM on April 28, 2026

Asston Pharmaceuticals confirms record date as April 17, 2026 for extraordinary general meeting scheduled on April 28, 2026 to approve statutory auditors and director appointments.

06 Apr 2026

companies

Asston Pharma Completes Key Appointments & EGM

Asston Pharmaceuticals successfully concluded board meeting on March 30, 2026, appointing CFO Sumit Pawar, two directors, and scheduling EGM for April 28, 2026 at 12:30 PM via video conferencing.

31 Mar 2026

companies

Asston Pharma Completes Key Appointments & EGM

Asston Pharmaceuticals successfully concluded board meeting on March 30, 2026, appointing CFO Sumit Pawar, two directors, and scheduling EGM for April 28, 2026 at 12:30 PM via video conferencing.

30 Mar 2026

companies

Asston Pharma Completes Key Appointments & EGM

Asston Pharmaceuticals successfully concluded board meeting on March 30, 2026, appointing CFO Sumit Pawar, two directors, and scheduling EGM for April 28, 2026 at 12:30 PM via video conferencing.

30 Mar 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800